BR112014014213A2 - agentes hemostáticos e método de utilização - Google Patents

agentes hemostáticos e método de utilização

Info

Publication number
BR112014014213A2
BR112014014213A2 BR112014014213A BR112014014213A BR112014014213A2 BR 112014014213 A2 BR112014014213 A2 BR 112014014213A2 BR 112014014213 A BR112014014213 A BR 112014014213A BR 112014014213 A BR112014014213 A BR 112014014213A BR 112014014213 A2 BR112014014213 A2 BR 112014014213A2
Authority
BR
Brazil
Prior art keywords
hemostatic agents
hemostatic
agents
Prior art date
Application number
BR112014014213A
Other languages
English (en)
Inventor
A Berman Dean
F Bristow Joseph
Original Assignee
Agratech Int Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agratech Int Inc filed Critical Agratech Int Inc
Publication of BR112014014213A2 publication Critical patent/BR112014014213A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/722—Chitin, chitosan
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A61K9/0017—Non-human animal skin, e.g. pour-on, spot-on
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0023—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2300/00—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices
    • A61L2300/40—Biologically active materials used in bandages, wound dressings, absorbent pads or medical devices characterised by a specific therapeutic activity or mode of action
    • A61L2300/418—Agents promoting blood coagulation, blood-clotting agents, embolising agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2400/00—Materials characterised by their function or physical properties
    • A61L2400/04—Materials for stopping bleeding

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Otolaryngology (AREA)
  • Materials Engineering (AREA)
  • Zoology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Materials For Medical Uses (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
BR112014014213A 2011-12-12 2012-12-12 agentes hemostáticos e método de utilização BR112014014213A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161569572P 2011-12-12 2011-12-12
PCT/US2012/069134 WO2013090357A1 (en) 2011-12-12 2012-12-12 Hemostatic agents and methods of use

Publications (1)

Publication Number Publication Date
BR112014014213A2 true BR112014014213A2 (pt) 2017-06-13

Family

ID=48613128

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014014213A BR112014014213A2 (pt) 2011-12-12 2012-12-12 agentes hemostáticos e método de utilização

Country Status (10)

Country Link
US (1) US20140336147A1 (pt)
EP (1) EP2790709A4 (pt)
JP (1) JP2015504867A (pt)
KR (1) KR20140107429A (pt)
CN (1) CN104114178A (pt)
BR (1) BR112014014213A2 (pt)
CA (1) CA2892904A1 (pt)
MX (1) MX2014006906A (pt)
RU (1) RU2014128291A (pt)
WO (1) WO2013090357A1 (pt)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10098857B2 (en) * 2008-10-10 2018-10-16 The Board Of Trustees Of The Leland Stanford Junior University Topical and transdermal delivery of HIF-1 modulators to prevent and treat chronic wounds
US10058490B2 (en) * 2014-12-24 2018-08-28 L'oreal Acoustically-activated cosmetic hydrogels
CA3058638A1 (en) * 2017-03-31 2018-10-04 Gel-E, Inc. Hydrophobically-modified polymer foams and methods of use
KR102128815B1 (ko) 2017-06-20 2020-07-10 홍선기 접착성과 비접착성의 이중막 구조를 갖는 장 문합 보호용 의료기구
US11890385B2 (en) 2017-12-20 2024-02-06 Stryker European Operations Holdings Llc Biomedical foam
CN108434506B (zh) * 2018-04-27 2021-06-25 温州医科大学附属第二医院（温州医科大学附属育英儿童医院） 一种负载纳米缓释药物胶束的膨胀海绵、制备方法及用途
KR102112539B1 (ko) * 2018-06-28 2020-05-19 에스케이바이오랜드 주식회사 2액형 지혈제 조성물 및 그 제조방법
EP4403194A2 (en) 2018-11-19 2024-07-24 Endomedix, Inc. Methods and compositions for achieving hemostasis and stable blood clot formation
US10517988B1 (en) 2018-11-19 2019-12-31 Endomedix, Inc. Methods and compositions for achieving hemostasis and stable blood clot formation
KR102211765B1 (ko) 2019-01-15 2021-02-03 주식회사 테라시온바이오메디칼 흡수성 골 지혈재 조성물 및 이를 이용한 골 지혈재 제조방법
CA3135980A1 (en) * 2019-03-05 2020-09-10 Medcura, Inc. System and method to reduce tissue or organ adhesion
ES2961107T3 (es) * 2019-07-12 2024-03-08 Cilag Gmbh Int Polvo hemostático
KR20220077353A (ko) 2020-12-02 2022-06-09 주식회사 테라시온 바이오메디칼 항생제를 포함하는 흡수성 골 지혈재 조성물 및 이의 제조방법
CN114558167A (zh) * 2022-03-09 2022-05-31 上海长征医院 一种快速止血喷雾及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3780700T2 (de) * 1986-05-14 1993-02-04 Ono Pharmaceutical Co Klebstoff fuer perkutane verabreichung.
US6673612B2 (en) * 1999-07-16 2004-01-06 Mirus Corporation Micellar systems
ATE424815T1 (de) * 2001-12-03 2009-03-15 Dor Biopharma Inc Stabilisierte umkehr-mizellen-zusammensetzungen und ihre verwendung
EP1778614A4 (en) * 2004-07-19 2008-09-24 Univ Massachusetts REVERSIBLE AMPHIPHILE POLYMERS
US20070237811A1 (en) * 2006-04-10 2007-10-11 Scherr George H Chitosan wound dressing
US9066885B2 (en) * 2007-03-16 2015-06-30 University Of Maryland, College Park Advanced functional biocompatible polymeric matrix containing nano-compartments
US8668899B2 (en) * 2009-11-13 2014-03-11 University Of Maryland, College Park Advanced functional biocompatible foam used as a hemostatic agent for compressible and non-compressible acute wounds

Also Published As

Publication number Publication date
RU2014128291A (ru) 2016-02-10
CN104114178A (zh) 2014-10-22
JP2015504867A (ja) 2015-02-16
US20140336147A1 (en) 2014-11-13
KR20140107429A (ko) 2014-09-04
EP2790709A4 (en) 2015-07-29
MX2014006906A (es) 2014-09-04
WO2013090357A1 (en) 2013-06-20
CA2892904A1 (en) 2013-06-20
EP2790709A1 (en) 2014-10-22

Similar Documents

Publication Publication Date Title
BR112014014213A2 (pt) agentes hemostáticos e método de utilização
CO6870033A2 (es) Compuestos terapéuticos y métodos de uso relacionados
BR112014001453A2 (pt) aditivo catalizador e método de preparação do mesmo
BR112013025355A2 (pt) combinações de compostos de inibidor de akt e abiraterona e métodos de uso
BR112013022525A2 (pt) dispositivos e métodos para enrijecimento de pele
DK2683731T3 (da) C4-monomethyl-triterpenoidderivater og fremgangsmåder til anvendelse deraf
BR112012017441A2 (pt) compostos e métodos
CO7010824A2 (es) Inhibidores de aplicación viral
BR112013021373A2 (pt) aparelho e método de bebida preparada
BR112013018469A2 (pt) dispositivos e métodos para tratamento de tecidos
BR112013012854A2 (pt) métodos de tratamento usando os inibidores de bcl-2 seletivos
ITMI20120946A1 (it) Metodo di determinazione di vibrazione e dispositivo di determinazione di vibrazione
BR112014010450A2 (pt) composição e método
BR112014006291A2 (pt) composição e utilização da composição
BR112014003774A2 (pt) inibidores de dyrk1 e usos dos mesmos
BR112014002716A2 (pt) anticorpos anti-poliubiquitina e métodos de uso
ITMI20120368A1 (it) Metodo di determinazione di vibrazione e dispositivo di determinazione di vibrazione
FI20115463A (fi) Jarru sekä menetelmä jarrun valmistamiseksi
BR112014005660A2 (pt) implantes revestidos e métodos relacionados
BR112013022766A2 (pt) método de administração de d-pirfenidona e kit
BR112014000022A2 (pt) 1-3-tiazepinas ciclopropil-fundidas como inibidores de bace 1 e/ou bace 2
BR112013028968A2 (pt) composições de desbridamento de feridas contendo seaprose e métodos de tratamento de feridas utilizando-as
BR112013030991A2 (pt) uso de gdc-0980 e método de tratamento de mesotelioma
BR112014025507A2 (pt) formulação vesicular e método de tratamento
DK2661274T3 (da) Sammensætninger og fremgangsmåder med aloepolysaccharider

Legal Events

Date Code Title Description
B11A Dismissal acc. art.33 of ipl - examination not requested within 36 months of filing
B11N Dismissal: publication cancelled [chapter 11.14 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 5A E 6A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO ARQUIVAMENTO PUBLICADO NA RPI 2521 DE 30/04/2019.

B350 Update of information on the portal [chapter 15.35 patent gazette]